The lipid-lowering drug obicetrapib produces the greatest reductions in the Alzheimer’s biomarker p-tau217 among APOE4 ...

The TROG 08.03 RAVES randomized controlled trial substudy examined quality of life after post-prostatectomy radiation therapy.

With War Secretary Pete Hegseth fueling a national conversation about testosterone, many men may wonder whether their own ...

Comorbid gout is associated with an increased risk for ischemic stroke in patients with atrial fibrillation, according to a nationwide cohort study.

Diranersen misses study's main goal but shows signs of cognitive benefit ...

Ashwin Kishtagari, MBBS, is Assistant Professor of Medicine in the division of hematology and oncology at Vanderbilt ...

Mezzion Pharmaceuticals today announced publication of "The FUEL FALD Study: Effects of Udenafil on Liver Stiffness and Fibrosis after Fontan" in the peer-reviewed journal Pediatric Cardiology. The ...

Diranersen demonstrated efficacy across all studied doses at 18 months, with consistent results across multiple prespecified ...

People living with early Alzheimer’s disease can now begin treatment with Leqembi without setting foot in an infusion center.

Patients with obesity-related heart failure who took semaglutide 2.4 mg weekly lost substantial weight and reported fewer ...

Alzheimer's Association International Conference (AAIC Meeting) 2026 July 12, 2026 11:15 AM EDTCompany ParticipantsTim Power - Head ...

Ionis Pharmaceuticals, Inc. today announced that its partner, Biogen, shared data from the Phase 2 CELIA study evaluating diranersen, an investigational antisense oligonucleotide (ASO) therapy ...